Gordon Guyatt

Impact

Papers

2

Total Citations

141

H-Index

2

About

Gordon Guyatt is a towering figure in evidence-based medicine, best known as the founding father of the GRADE approach to clinical practice guidelines. His research centers on clinical epidemiology, research methodology, and the synthesis of evidence to guide patient care. Among his most impactful contributions are systematic reviews and meta-analyses that quantify baseline risks for venous thromboembolism (VTE) and bleeding in urological cancer surgery, providing procedure-specific estimates that enable surgeons to balance thromboprophylaxis benefits against harms. His work, including a highly cited 2017 meta-analysis (126 citations), has reshaped perioperative decision-making. Additionally, an international survey (2020) characterized global variation in thromboprophylaxis use, highlighting the need for standardized protocols. Guyatt’s influence extends far beyond urology; his methodological innovations have transformed how clinicians and guideline developers worldwide evaluate evidence, with his publications collectively cited tens of thousands of times. A professor at McMaster University, he remains a leading voice in promoting rigorous, patient-centered research and teaching the next generation of evidence-based practitioners.

Research Focus

Key Achievements

2
H-Index
2
Papers
141
Total Citations
71
Avg Citations/Paper
🏆 Most Cited Paper
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
126 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Impact

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago